FEI
FIRST TRUST MLP AND ENERGY INCOME FUND
stock NYSE

Respectfully, this has nothing to do with the broader market pumping.
When the S&P 500 jumped nearly 10% on April 9, Optimi barely moved. This stock doesn’t follow macro trends. It moves on direct catalysts.
This week, two major announcements dropped:
1. FDA registration – Optimi just secured an FDA Establishment Identifier (FEI) number, allowing them to supply GMP-grade MDMA and psilocybin to U.S. researchers and therapy providers.
2. Record MDMA export – They completed their largest MDMA shipment yet, supplying GMP doses to Australia under the Authorised Prescriber Scheme for PTSD treatment.
These are real, material developments. That’s why the stock is moving. Not because of some general market reaction.

Respectfully, this has nothing to do with the broader market pumping.
When the S&P 500 jumped nearly 10% on April 9, Optimi barely moved. This stock doesn’t follow macro trends. It moves on direct catalysts.
This week, two major announcements dropped:
1. FDA registration – Optimi just secured an FDA Establishment Identifier (FEI) number, allowing them to supply GMP-grade MDMA and psilocybin to U.S. researchers and therapy providers.
2. Record MDMA export – They completed their largest MDMA shipment yet, supplying GMP doses to Australia under the Authorised Prescriber Scheme for PTSD treatment.
These are real, material developments. That’s why the stock is moving. Not because of some general market reaction.